Sam Ropp - 15 Dec 2023 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role: Chief Commercial Officer
Signature: /s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 15 Dec 2023
Net transactions value: $0
Form type: 4
Filing time: 18 Dec 2023, 17:44:01 UTC
Previous filing: 15 Sep 2023
Next filing: 13 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OMIC	Common Stock	Options Exercise		+4,188	+50%		12,563	15 Dec 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OMIC	Restricted Stock Units	Options Exercise		-4,188	-7.1%		54,437	15 Dec 2023	Common Stock	4,188		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2	Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3	The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.